Chidamide Maintenance After Autologous Hematopoietic Stem Cell Transplantation for Relapsed, Refractory or High-risk Lymphoma
Clinical trial NCT03611231 · UNKNOWN
Trial details
- NCT number
- NCT03611231
- Sponsor
- Peking University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-01
- Primary completion
- 2020-12-30
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.